ask="1.15"
ask_size="200"
average_daily_volume="1329590"
bid="0.98"
bid_size="6000"
book_value="0.61"
change="+0.02"
change_from_200_day_moving_average="-1.32"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-3.90"
change_From_52_week_low="0.53"
change_in_percent="+1.98%"
close="1.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.24"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="0.19"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.05"
high_52_weeks="4.93"
last_trade_date="2/9/2017"
last_trade_price="1.03"
last_trade_size="248"
last_trade_time="3:59pm"
low="0.98"
low_52_weeks="0.50"
market_capitalization="7.36M"
moving_average_200_day="2.35"
moving_average_50_day="0.97"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.33"
open="1.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-56.21%"
percent_change_from_50_day_moving_average="+5.89%"
percent_change_from_52_week_high="-79.11%"
percent_change_from_52_week_low="+106.00%"
previous_close="1.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.42"
price_per_book="1.67"
price_per_sales="2.82"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.74"
stock_exchange="NCM"
symbol="OPXA"
volume="265338"
weeks_range_52="0.50 - 4.93"
